of borderline significancep = 0.09
However SREBP-1c expression was unchanged and the increase in the mRNA level of ChREBP, considered as a target of LXR [ 41 ] was of borderline significance (p = 0.09).
However SREBP-1c expression was unchanged and the increase in the mRNA level of ChREBP, considered as a target of LXR [ 41 ] was of borderline significance (p = 0.09).
In non-diabetic subjects there was no difference in mRNA concentrations between MIT and atheroma whereas in diabetic patients there was in plaques a clear trend for higher values with concentrations, for ACC1, Srebp-1c and ChREBP near to those observed in plaques of non-diabetic subjects.